HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dolunay Gülmez Selected Research

pembrolizumab

4/2023Necrotizing pneumonia due to Aspergillus and Salmonella after immune checkpoint inhibitor treatment: An unusual case and review of the literature.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dolunay Gülmez Research Topics

Disease

8Infections
01/2024 - 06/2008
2Mycoses (Diseases, Fungus)
04/2023 - 01/2021
2Necrotizing Pneumonia
04/2023 - 10/2011
2Candidemia
08/2021 - 10/2016
1Rhinosinusitis
01/2024
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2024
1Hemolysis
01/2024
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
04/2023
1Neoplasms (Cancer)
04/2023
1Dyspnea (Shortness of Breath)
04/2023
1Coinfection
07/2022
1Soft Tissue Infections
07/2012
1Pneumonia (Pneumonitis)
10/2011
1Myalgia
10/2011
1Respiratory Insufficiency (Respiratory Failure)
10/2011
1Fever (Fevers)
10/2011
1Empyema
10/2011
1Cough
10/2011
1Rheumatic Diseases (Rheumatism)
04/2003
1Rheumatoid Arthritis
04/2003

Drug/Important Bio-Agent (IBA)

3Fluconazole (Zonal)FDA LinkGeneric
04/2023 - 01/2021
1posaconazoleFDA Link
01/2024
1EsterasesIBA
01/2024
1Phospholipases (Phospholipase)IBA
01/2024
1Peptide Hydrolases (Proteases)FDA Link
01/2024
1AcidsIBA
01/2024
1CoagulaseIBA
01/2024
1Antifungal AgentsIBA
04/2023
1AzolesIBA
04/2023
1Immune Checkpoint InhibitorsIBA
04/2023
1pembrolizumabIBA
04/2023
1ChlorhexidineIBA
07/2022
1Povidone-Iodine (Betadine)FDA LinkGeneric
07/2022
1mesoglycanIBA
01/2022
1AnidulafunginFDA Link
08/2021
1Caspofungin (Cancidas)FDA Link
08/2021
1EchinocandinsIBA
01/2021
1Anti-Bacterial Agents (Antibiotics)IBA
01/2021
1Biocompatible Materials (Biomaterials)IBA
04/2016
1Virulence Factors (Pathogenicity Factors)IBA
07/2012
1Panton-Valentine leukocidinIBA
07/2012
1Clindamycin (Cleocin)FDA LinkGeneric
10/2011
1Meropenem (Merrem)FDA LinkGeneric
10/2011
1Linezolid (Zyvox)FDA Link
10/2011
1Clarithromycin (Biaxin)FDA LinkGeneric
10/2011
1Levofloxacin (Levaquin)FDA Link
10/2011
1Carbapenems (Carbapenem Antibiotics)IBA
06/2008
1beta-Lactamases (beta-Lactamase)IBA
06/2008
1Biomarkers (Surrogate Marker)IBA
04/2003
1Anti-Citrullinated Protein AntibodiesIBA
04/2003

Therapy/Procedure

3Therapeutics
10/2016 - 10/2010
1Induction Chemotherapy
01/2024
1Drug Therapy (Chemotherapy)
04/2023
1Continuous Ambulatory Peritoneal Dialysis (CAPD)
01/2022
1Catheters
01/2022
1Withholding Treatment
10/2011
1Chest Tubes (Chest Tube)
10/2011